ESR1 and invasive ductal breast carcinoma: The majority of women were aged 31-40 years (88.1%), with infiltrating ductal carcinoma (IDC) subtype (84.6%), stage T1-2 (86.4%), ER positive (72.7%), and HER2 negative (76.3%) disease.